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Abstract
Background: Hepatitis B virus (HBV) and Human immunodeficiency virus (HIV) infection in pregnancy is associated
with direct effect of pregnancy and potential viral transmission from mother to newborn. In Tanzania very little in
known on prevalence of HBV infection and their associated factors among pregnant women in lower health facilities.
The main objective of the study was to determine the prevalence of HBsAg, HIV and HBV-HIV co-infection among
pregnant women attending antenatal clinics in Dar es Salaam.
Methods: This cross sectional study was conducted in three Temeke municipal health-care facilities between May 2014
and June 2014. A total of 249 pregnant women attending antenatal clinic (ANC) were consecutively enrolled in the
study. A data collection tool was used to extract socio-demographic characteristics from ANC card. Commercial
ARCHITECT® ci4100™ was used to assess HBsAg status and liver function (Alanine amino-transferase (ALAT).
HIV status was determined by anti-HIV antibody test.
Results: Of 249 pregnant women enrolled the median age was 25 years (IQR 22–30) and most of them were
married (72.4%). The overall prevalence of HBsAg and HIV were 8.03% (95% CI: 5.0–12.1%) and 17.2% (95% CI:
12.8–22.5%), respectively. HBV/HIV co-infection rate was 2.8% (95% CI; 1.3–5.4%). HBsAg positive rate was significantly
high in women who were HIV positive (p < 0.05). Being employed /student were less associated with HBV infection
(aOR 0.35, 95% CI 0.13–0.95). Only 3 (15%) of pregnant women with HBsAg positive had abnormal ALAT.
Conclusions: High prevalence of HBV and HIV infections among pregnant women were reported in this setting thus
calls for the national expansion of the integration of prevention of mother-to-child transmission (PMTCT) services for
HBV infection.
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Background
Chronic hepatitis B virus and HIV infections remain a
major global public health concern. Worldwide, about
350 million individuals are chronically HBV infected;
half of them acquired infection either perinatal or in
early childhood, majority found in endemic areas [1].
Annually, estimated more than 600,000 people die as a
result of hepatitis B virus related liver diseases [2]. The
risk of progression to chronic disease is inversely pro-
portional to the age at which infection is acquired. Infec-
tion to women during pregnancy is associated with
increased risks of transmission to a newborn [3, 4]. With
impaired immunity in new-born, infection acquired dur-
ing this stage may lead to further progression to liver
cirrhosis and hepatocellular carcinoma later in life. HBV
and HIV share the common mode of transmission and
co- infection in pregnancy is associated with increased
morbidity, mortality and untoward outcomes to a new-
born. HIV co-infection increases HBV replication, lead-
ing to higher levels of detectable virus [5], and increases
likelihood of perinatal transmission of HBV.
Prevention of mother to child transmission of hepatitis
B virus is the most important strategy in the control of
infection to newborn. Hepatitis B virus vaccine was in-
troduced into the Tanzanian immunization and vaccine
development program since2002 given at 4, 8, and
12 weeks as a DPT-HB [6]. However, the country has yet
to introduce strategies to reduce the vertical transmis-
sion of HBV including screening for HBsAg, use of anti-
virals in the third trimester of pregnancy and at-birth
prophylaxis of newborns which greatly reduces the risk
of transmission [7, 8].
The prevalence of HBsAg in Tanzania varies consider-
ably from 1.2 to 17.3% between different cohorts.
Prevalence of 9.2 and 3.2% have been reported among
HIV infected cohort in Southern rural and Northern
Tanzania, respectively [9, 10]. At Muhimbili national
hospital, in Dar es Salaam recent studies reported
HBsAg prevalence of 1.2, 3.9, 8.8 and 17.3% among HIV
children, pregnant women, blood donors and HIV
adults, respectively [11–14]. These indicate that different
cohort in different geographical locations at different
level of health facilities have dissimilar prevalence of
HBV infection. Very little in known on prevalence of
Hepatitis B virus infection among pregnant women
attending antenatal clinics at municipal hospital and
health centers in Tanzania. Few studies reported previ-
ously were mostly conducted at referral and tertiary hos-
pital in which population varies from district hospital
and health centers.
World Health Organization (WHO) has called for in-
tegrated and standardized prevention of mother-to-child
transmission (PMTCT) for HIV, syphilis and HBV [15].
Despite the call Tanzania has not scaled up PMTCT
services for HBV infection. Understanding the epidemi-
ology of Hepatitis B infections among pregnant women
at different levels in Tanzania is of importance for opti-
mizing HBV infection control strategies. Therefore, we
conducted this study in Temeke municipality which has
high annual growth rate in Tanzania, aiming at deter-
mining the prevalence of HBsAg and HIV among preg-
nant women attending antenatal clinics.
Methods
Study design and settings
This cross sectional study among pregnant women at-
tending antenatal clinics (ANC) was conducted between
May 2014 and June 2014. The study was carried out at 3
health-care facilities in Temeke municipal including
Temeke hospital, Zakheem and Kizuiani health centers.
Temeke Municipality is one of the three Municipalities
within the Dar es Salaam City Council with a population
of 1,368,881 and an estimated growth rate of 6.6% per
year compared to national annual growth rate of 2.9%.
Study population, sample size and sampling procedure
Participants were pregnant women attending ANC dur-
ing the study period. The sample size was calculated
using Kish and Lisle formula for cross sectional studies,
n = z2 p(1-p)/d2. Where: z = Z score for 95% confidence
interval = 1.96, p = prevalence, d = tolerable error =3%. A
prevalence of 3.9% was used as p for a previous study in
Tanzania [12]. Consequently, the minimal sample size of
the study population was 159 participants. However, we
consecutively recruited all pregnant women who were
attending ANC clinic during the study period to increase
the power of our study. Therefore a total of 249 preg-
nant women who met eligible criteria and consenting to
participate in the study were recruited. Inclusion criteria
was pregnant women aged > 18 years and women were
excluded if knew their HBsAg status and if not residing
in Temeke municipal.
Data collection
Data were extracted from antenatal clinic card using
data standard structured questionnaires. Information
on social demographic characteristics including age,
education levels, occupational status and marital sta-
tus were recorded.
Specimen collection, transport and storage
Five milliliters of blood were collected aseptically by
veno-puncture into plain vacutainer tube. Half portion
was used for HIV screening on site. Another half portion
was packed into cool box then immediately delivered to
central pathology laboratory at Muhimbili national hos-
pital for further processing where sera were immediately
separated after centrifugation.
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Laboratory procedures
Detection of hepatitis B surface antigen
Commercially available ARCHITECT® ci4100™ Integrated
Immunoassay and Clinical Chemistry System (Abbott
Laboratories, Abbott Park, IL, USA) was used to assess
hepatitis B surface antigen (HBsAg) status. All specimens
who were HBsAg positive, Alanine amino-transferase
(ALT) were measured to assess liver function. The
Architect C8000 automated analyzer was used to de-
tect ALT levels. An Alanine amino-transferase value >
38 IU/L indicated abnormal liver function.
HIV screening
HIV infection among pregnant women was determined
by anti-HIV antibody test (rapid test currently used in
national algorithm for Tanzania). Alere Determine™
HIV1/2 (Alere Medical Co. Ltd. Matsudo-shi, Chiba-
ken, Japan) was used for screening and negative results
underwent no further testing. Positive samples were re-
tested with Uni-Gold™ HIV (Trinity Biotech Manufac-
turing Ltd. Bray, Ireland). Specimens that were positive
on both tests were considered HIV antibody positive. All
discordant specimens were sent to Muhimbili national
hospital for resolution. In addition few randomly se-
lected specimens were sent to Muhimbili national hos-
pital for quality assurance.
Data analysis
Data were entered and analyzed using Microsoft excel
2010 and Stata version 11.2 respectively. Wilcox rank-
sum test and Fisher’s exact test were performed to
examine the difference between categorical variables. A
p-value of <0.05 was considered statistically significant.
We determined the association between, the outcome
HBsAg and associated factors using the univariate (crude
odd ratio-cOR) and multivariate logistic regression
(adjusted odd ratio-aOR) were performed to identify in-
dependent factors associated with HBsAg positivity. The
point estimates are presented as odd ratio (OR) and
their corresponding 95% Confidence Interval (95% CI).
Results
Study participants’ characteristics
A total of 249 pregnant women were enrolled in the
study. Their age ranged from 18 to 40 years with median
age of 25 years (IQR 22–30). The age group with highest
proportion was < 24 years contributing 45.8% of all par-
ticipants. Nearly-half (46.2%) of participants had second-
ary level of education and most participants were
married 72.4%. Almost forty percent (39.8%) of the study
participants were in second trimester and 52% were
petty traders (Table 1).
HBV and HIV infection
Of 249 pregnant women, the prevalence of HBsAg was
8.03% (95% CI: 5.0–12.1%). The HBsAg positive were
simultaneously increasing with age, with women aged
more than 35 years having the highest prevalence com-
pared to other age groups. The HBsAg was significantly
higher among women with primary school education
(12.5% p < 0.05) (Table 2). Women who were married/
cohabit and those who had no employment significantly
had higher prevalence of HBsAg (p < 0.05). The gestation
age was not statistically associated with HBsAg. The
overall prevalence of HIV among this cohort was 17.2%
(95% CI: 12.8–22.5). About 2.8% (95% CI; 1.3–5.4) of
pregnant women were HBV and HIV co-infected. The
rate of HBsAg positive was significantly higher in
women who were HIV positive compared to HIV nega-
tive (p < 0.05). Of 20 pregnant women with HBsAg posi-
tive only 3 (15%) had abnormal elevated Alanine
aminotransferase (ALAT).
Table 1 Socio-demographic characteristics of the study participants
Variables Frequency (%)
Age, median (IQR) 25 (22–30)
Age groups
< 24 114 (45.8)
25–30 86 (34.5)



















1st trimester 80 (32.1)
2nd trimester 99 (39.8)
3rd trimester 70 (28.1)
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Association of HBsAg and clinical-socio demographic
characteristics
In a univariate analysis it was found that an increase in age
was associated with increased odds of HBsAg positive (aOR
1.05 (0.97–1.14), though this association was not statistically
significant (Table 3). Pregnant women who were HIV posi-
tive were nearly three times more likely to be HBsAg posi-
tive (cOR 2.89, 95% CI 1.08–7.73) than women who were
HIV negative. Women who were married/cohabiting were
also more likely to be HBsAg positive compared to those
who were single/divorced (cOR 5.58, 95% CI 0 .73–42.69).
Having secondary /college education (cOR 0.39, 95% CI
0.15–0.98) and being employed/student (cOR 0.31, 95% CI
0.12–0.78, p < 0.05) were significantly at reduced risk of
Hepatitis B virus infection. In multivariate analysis, after
adjusting for potential confounding factors, Women who
were employed/student remained at reduced risk of being
Hepatitis B virus infected (aOR 0.35, 95% CI 0.13–0.95).
Discussion
In the present study, the overall prevalence of HBsAg
among pregnant women was 8.03%. In accordance to
WHO interpretation, the finding grades the study setting
an area with high HBV disease endemicity [16]. Our
finding is in agreement with previous studies on HBsAg
prevalence among pregnant women from high HBV en-
demic areas [17–19]. In comparison to other studies
conducted in Tanzania, the prevalence of HBV among
pregnant women in our study was higher than that re-
ported in rural-southern (6.3%), northern (4.2%) and at
national hospital (3.9%) [12, 20, 21]. On the other hand,
the prevalence was lower than that reported previously
among pregnant women in Kenya (9.3%), Uganda
(11.8%) and Cameroon (10.2%) [22–24]. The observed
variations could be attributable to geographical differ-
ences, since our study was performed in highly popu-
lated urban setting compared to previous studies in
Tanzania and elsewhere.
In the current study, the prevalence of HBsAg was sig-
nificantly high in pregnant women who had primary
level of education compared to those with secondary/
college level of education. Our observation was in agree-
ment to a previous conducted in Nigeria [25]. Moreover,
pregnant women who had no employment and those
who were married or cohabiting had high prevalence of
HBsAg. These findings are in contrast with previous re-
sults reported in Uganda (Married 10.6%), Ethiopia (low
income 1.13%, married 2.64%) [23, 26]. It is not clear
whether the differences observed from our study was
due to high population of women who were unemployed
and married/cohabiting or involvement in risky behavior
in these group. Unemployment could fuel women to en-
gage in risky sexual behavior including commercial sex,
thus increasing risk of infection. Age of participants and
gestation of the pregnancy were not significantly associ-
ated with high prevalence of HBsAg in line with other
previous study in Ethiopia [27].
The overall prevalence of HIV among pregnant women
in our study exceeded the recent reported national HIV
prevalence among pregnant women [28]. Similarly, the
prevalence was higher compared to results from previous
studies among pregnant women in Tanzania [12, 29].
Likewise, the prevalence was higher than that reported in







Age, median (IQR) 28 (23.5–31) 25 (22–29) 0.13*
Age groups
< 24 8 (7.0) 106 (93.0)
25–30 7 (8.14) 79 (91.9) 0.79
> 31 5 (10.2) 44 (89.8)
Education status
Primary 12 (12.5) 84 (87.5) 0.04
Secondary/College 8 (5.2) 145 (94.8)
Marital status
Single/divorced 1 (1.9) 52 (98.1) 0.047#
Married/Cohabit 19 (9.7) 177 (90.3)
Occupation status
Unemployed 10 (15.6) 54 (84.4) 0.01
Employed/student 10 (5.4) 175 (94.6)
HIV status
Positive 7 (16.3) 36 (83.7) 0.029
Negative 13 (6.3) 193 (93.7)
*Wilcox ranksum test p-value; #Fisher’s exact p-value
Table 3 Association of positive HBsAg with clinico-demographic characteristics
Variable cOR (95% CI) p-value aOR (95% CI) p-value
Age in years 1.05 (0.97–1.14) 0.24 1.02 (0.93–1.13) 0.624
HIV 2.89 (1.08–7.73) 0.035 2.24 (0.77–6.48) 0.137
Married/Cohabiting 5.58( 0 .73–42.69) 0.098 4.66 (0.53–41.0) 0.165
Secondary/College education 0.39 (0.15–0.98) 0.046 0.41 (0.15–1.1) 0.076
Employed/Student 0.31 (0.12–0.78) 0.013 0.35 (0.13–0.95) 0.039
cOR crude odd ratio, CI confidence interval, aOR adjustable odd ratio
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recent studies in Uganda (9.3%) and Ethiopia (6.6%),
which are HIV endemic areas [23, 27]. The observed dif-
ferences to this study maybe attributable to risk of sexual
behavior since most of participants in the current study
were less than 24 years, hence likely to be involved in high
risky sexual behavior like prostitution. Likewise, this is the
age were most participants may commence unprotected
sexual interaction. In addition the study site has estimated
population growth rate of 6.6% per year compared to na-
tional annual population growth rate of 2.9%, displaying
high sexual activities in this setting [30], explaining the
observed finding.
Prevalence of HBsAg was significantly high in preg-
nant women who were HIV positive compared to those
who were HIV negative (p < 0.05). This finding is in con-
trast to HBsAg prevalence reported among HIV-positive
and HIV-negative pregnant women at a tertiary hospital
in Tanzania [12]. On the Contrary, studies from Sub-
Saharan Africa have reported similar positivity rate of
HBsAg prevalence among HIV-positive and HIV nega-
tive pregnant women [23, 31, 32]. The predominant
mode of transmission is still thought to be childhood/
perinatal in this country. The higher prevalence of HBV
infection among HIV patients observed in our study
could be due to those patients being less able to clear it.
The rate of HBV and HIV co-infection in our study
was 2.8%. This rate was higher than that reported
previously from a national hospital in Dar es Salaam,
Tanzania [12]. Furthermore, the prevalence of HBV/HIV
co-infection among pregnant women found in our study
was higher than the previous reports in Nigeria (0.24%),
Ethiopia (0.6%) and Cameroon (1.5%) [24, 33, 34]. How-
ever, the prevalence of HBsAg in the current study was
lower than that reported from a recent study among
pregnant women in South Africa (3.1%) [35]. The ob-
served low HBV/HIV co-infection rates in settings of
high HBV endemicity could be explained by the fact
that the main routes of transmission of HBV in Sub-
Saharan Africa could be vertical and likely occurs in
early childhood.
Our study found that employment and being students
were independent factors associated with reduced risk of
HBV infection (aOR = 0.35; 95% CI 0.13–0.95). The find-
ing of employment and students being protective to
HBV infections was contrary to studies conducted
earlier in Tanzania and elsewhere within the region
[12, 27, 32]. Similar to other previous reports, marital
status and education levels were not independently
associated with HBV infections. HIV was also not in-
dependently associated with HBV infection, despite
showing association in bivariate analysis. Similar finding
was observed in previous studies among pregnant women
in Malawi, Ethiopia and Cameroon [27, 32, 36]. In spite of
lack of association between HBV and HIV in our study,
prevalence of these infections remains high in Tanzania,
as observed in the current study.
Our study had some limitations; detection of other
HBV surrogate markers (HBeAg, HBc-antibodies, HBV
DNA) and Hepatitis C virus were not possible due to
financial constraints. We did not ascertain risk factors
for HBV infection because of recall biases and design of
the study. Despite that, our findings are based on a sub-
stantial sample size and the inclusion of municipal and
health centers minimized the selection biases, since
these are catchment settings where both uncomplicated
and complicated cases are first seen.
Conclusions
Our study findings suggest high prevalence of HBV and
HIV infection among pregnant women in municipal health
facilities in Dar es Salaam, Tanzania, while HBV/HIV co-
infection is low. The results suggest that perinatal transmis-
sion is a common mode of HBV transmission in our
setting. Based on our finding, we advocate integrating HBV
infection into PMTCT program in Tanzania. Testing for
HBsAg should be recommended for every pregnant women
and possible prevention of mother-to-child transmission
measures should be considered.
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